FiercePharma

The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome

The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome The only transdermal dopamine agonist*1 system, which helps ...
FierceBiotech

Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome

ATLANTA, Dec. 13 /PRNewswire/ -- UCB announced today that the supplemental New Drug Application (sNDA) for the use of Neupro(R) as a treatment for moderate-to-severe restless legs syndrome (RLS) has ...
FierceBiotech

Press Release: FDA Approves Schwarz Pharma's Neupro for the Treatment of Early-Stage Parkinson's Disease in the U.S.

FDA Approves Schwarz Pharma's Neupro for the Treatment of Early-Stage Parkinson's Disease in the U.S. MONHEIM, Germany, May 10 -- SCHWARZ PHARMA announced today that the U.S. Food and Drug ...
FiercePharma

Neupro Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome

Neupro® (Rotigotine Transdermal System) is approved to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary restless legs syndrome ...
Healthline

Neupro Interactions: Alcohol, Medications, and Others

Neupro (rotigotine) is a prescription skin patch used to treat Parkinson’s disease and restless legs syndrome in adults. Neupro has interactions with other drugs and alcohol. For example, it can ...